Late-phase clinical trials are designed to determine effectiveness and further study the safety of an investigational drug in human patients. At Charles River, our extensive global portfolio of support services provides complementary resources and expertise to enhance your studies.
During Phase II, III, and IV clinical trials, a multitude of scientific and professional services are required to satisfy the regulatory requirements of drug licensing authorities. Charles River offers a wide range of clinical support services, specialty toxicology programs, process manufacturing testing, and regulatory advisory personnel to help bring your new chemical compound, biologic, or device into the marketplace.